Fig. 1From: Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patientsRegional recurrence-free survival of the patients included in this study. No significant difference between the SaphRes and SaphSpar groups was observedBack to article page